AbbVie Declares Quarterly Dividend

Loading...
Loading...

NORTH CHICAGO, Ill., Sept. 6, 2019 /PRNewswire/ -- The board of directors of AbbVie Inc. ABBV declared a quarterly cash dividend of $1.07 per share. 

The cash dividend is payable November 15, 2019 to stockholders of record at the close of business on October 15, 2019.

Since the company's inception in 2013, AbbVie has increased its dividend by 168 percent.  AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, LinkedIn or Instagram.

SOURCE AbbVie

Ex-Date
ticker
name
Dividend
Yield
Announced
Record
Payable
Posted In: DividendsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...